St. Jude Medical, Inc. is focused on the development, manufacture and distribution of cardiovascular medical devices for the global cardiac rhythm management, cardiovascular and atrial fibrillation therapy areas, and interventional pain therapy and neurostimulation devices for the management of chronic pain and movement disorders. The Company's product categories include tachycardia implantable cardioverter defibrillator systems; atrial fibrillation products (electrophysiology introducers and catheters, advanced cardiac mapping, navigation and recording systems and ablation systems); bradycardia pacemaker systems; vascular products (vascular closure products, pressure measurement guidewires, optical coherence tomography imaging products, vascular plugs, heart failure monitoring devices and other vascular accessories); structural heart products (heart valve replacement and repair products and structural heart defect devices); neuromodulation products, and Thoratec products.
Industry, Sector and Symbol
Industry N/A
Sub-IndustryHealth Care Equipment
SectorN/A
SymbolNYSE:STJ
CUSIP79084910
Phone+1-651-7562000
Debt
Debt-to-Equity Ratio1.20
Current Ratio1.93
Quick Ratio1.31
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A
Profitability
EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net Margins14.14%
Return on Equity19.40%
Return on Assets6.75%
Miscellaneous
Employees18,000
Outstanding Shares285,590,000
St Jude Medical (NYSE:STJ) Frequently Asked Questions
What is St Jude Medical's stock symbol?
St Jude Medical trades on the New York Stock Exchange (NYSE) under the ticker symbol "STJ."
How were St Jude Medical's earnings last quarter?
St Jude Medical Inc (NYSE:STJ) issued its earnings results on Wednesday, July, 20th. The medical technology company reported $1.06 EPS for the quarter, meeting the Thomson Reuters' consensus estimate of $1.06. The medical technology company earned $1.56 billion during the quarter, compared to the consensus estimate of $1.55 billion. St Jude Medical had a net margin of 14.14% and a return on equity of 19.40%. The business's quarterly revenue was up 10.8% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.07 earnings per share. View St Jude Medical's Earnings History.
Has St Jude Medical been receiving favorable news coverage?
News coverage about STJ stock has trended somewhat positive on Saturday, Accern Sentiment Analysis reports. Accern identifies positive and negative news coverage by reviewing more than 20 million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. St Jude Medical earned a news impact score of 0.17 on Accern's scale. They also gave headlines about the medical technology company an impact score of 46.92 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company's share price in the near term.
How do I buy shares of St Jude Medical?
Shares of STJ can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is St Jude Medical's stock price today?
One share of STJ stock can currently be purchased for approximately $80.82.
How can I contact St Jude Medical?
St Jude Medical's mailing address is 1 Saint Jude Medical Dr, SAINT PAUL, MN 55117-1789, United States. The medical technology company can be reached via phone at +1-651-7562000.
MarketBeat Community Rating for St Jude Medical (STJ)
MarketBeat's community ratings are surveys of what our community members think about St Jude Medical and other stocks. Vote "Outperform" if you believe STJ will outperform the S&P 500 over the long term. Vote "Underperform" if you believe STJ will underperform the S&P 500 over the long term. You may vote once every thirty days.
